Access Pharmaceuticals, Inc. (ACCP.OB) Announces Sponsorship of Oral Mucositis Symposium for MASCC Conference Attendees
Access Pharmaceuticals, Inc., a biopharmaceutical company focused on cancer and supportive care, announced this morning that it is sponsoring an Oral Mucositis Symposium today for researchers and health care professionals attending the Multinational Association of Supportive Care in Cancer (MASCC) Conference in Vancouver, B.C. later this week. To further educate and build awareness of the debilitating side effect of anticancer treatments, the Oral Mucositis (OM) Symposium will feature leading industry experts covering various topics concerning the disease, from pathogenesis and clinical factors to prevention and management of oral mucositis. Hosting the OM Symposium is part of Access Pharma's strategy for…